Clinical Trial Update: Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ferric(III) carboxymaltose infusion with oral iron supplementation for treating anemia in colorectal cancer patients undergoing surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Colorectal Carcinoma

Drugs mentioned

• Ferric(III) Carboxymaltose (ferric carboxymaltose)
• Oral iron supplementation

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Anemia, Colorectal Carcinoma | Phase 4 | Status: UNKNOWN